September 2025 in “Journal of the American Academy of Dermatology” Ritlecitinib may help treat alopecia areata by protecting hair follicles.
November 2024 in “SKIN The Journal of Cutaneous Medicine” Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.
July 2019 in “bioRxiv (Cold Spring Harbor Laboratory)” Mixing equal parts of honey and ghee is harmful.
November 2021 in “Skin appendage disorders” Self-induced hair loss should be considered in patients with androgenetic alopecia.
Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.
December 2025 in “Journal of Pharmacy And Bioallied Sciences” Personalized Ayurvedic treatment can effectively regrow hair in androgenetic alopecia.
March 2026 in “Voprosy dermatologii i venerologii/Dermatologiâ ža̋ne veneralogiâ ma̋selelerì” Dermatophytes, like Trichophyton rubrum, can cause allergies and chronic inflammation.
2 citations
,
June 2024 in “Dermatology” Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.
Calcium hydroxide in an ayurvedic product caused hair breakage.
1 citations
,
June 2023 in “Journal of Natural Remedies” Ayurveda may help treat severe hair loss.
Ritlecitinib significantly regrows scalp hair in people with alopecia areata.
March 2026 in “SKIN The Journal of Cutaneous Medicine” Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.
March 2018 in “Journal of Pre-Clinical and Clinical Research” Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.
June 2025 in “International Journal of Ayurveda and Pharma Research” Ayurvedic treatments can effectively regrow hair and prevent recurrence in alopecia areata.
January 2025 in “Bioengineering” Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.
1 citations
,
February 2023 in “International Journal of Research in Ayurveda and Pharmacy” Ayurvedic treatment helped a 12-year-old boy regrow hair safely.
55 citations
,
April 2008 in “Clinical Genetics” A new mutation in the ST14 gene was found in a patient with ARIH syndrome, showing milder symptoms and no tooth issues.
October 2024 in “International Journal of Research in Ayurveda and Pharmacy” Jeemuta Bhringadi Taila may help reduce hair loss and promote regrowth.
January 2024 in “American journal of clinical dermatology” Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.
September 2019 in “International journal of research in ayurveda and pharmacy” Ayurvedic treatment with Bhringraj Vati and coconut oil was safe and effective for reducing hair fall.
6 citations
,
January 2013 in “Journal of Ayurveda and integrative medicine” The detoxification process made Abrus precatorius seeds safe and effective for use.
Jockeys using diuretics without potassium supplements can face health problems.
February 2026 in “Contact Dermatitis” Avoiding exposure to certain grasses can prevent skin allergies, highlighting the importance of proper sanitation.
August 2021 in “Indian dermatology online journal” A young boy with a rare skin and nail condition improved significantly with simple topical treatments.
4 citations
,
March 2024 in “International Journal of Surgery Case Reports” February 2026 in “The Journal of Dermatology” Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.
23 citations
,
October 2024 in “British Journal of Dermatology” Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.
1 citations
,
January 2023 in “AYUSHDHARA” Nilibhringadi Taila is effective for improving hair quality and promoting growth.
September 2024 in “Annals of Medicine and Surgery” Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.